5PDCell-based immunotherapy combining encapsulation cell technology and irradiated autologous tumor cells: A novel technology platform that is both safe and feasible. Results from first in man trial

Mach, N.; Migliorini, D.; Vernet, R.; Belkouch, M.-C.; Luy, P.; Ancrenaz, V.; Py, C.; Grogg, J.; Harboe-Schmidt, P.; Bouche, N.

doi:10.1093/annonc/mdv513.05

research article

5PDCell-based immunotherapy combining encapsulation cell technology and irradiated autologous tumor cells: A novel technology platform that is both safe and feasible. Results from first in man trial

Mach, N.

•

Migliorini, D.

•

Vernet, R.

more

2015

Annals of Oncology

Name

mdv513.05.pdf

Type

Publisher's version

Access type

openaccess

Size

36.02 KB

Format

Adobe PDF

Checksum (MD5)

4449298f95b79695803235adcd370ce7